Dianalitics
Hudson Technologies Inc.
HDSN · v1 · 2026-07-09
hourglass
Loading…
Preparing the latest DD data, styles and content.
72OpportunityDD: Jul 09, 2026Analyst: 79
paidReference price
USD 6.44 (09/07/2026)
domainMkt cap
$266M
pie_chartShares
42.05M
candlestick_chart52W
$4.64-$10.52
trending_downShort interest
3.0%
INFONASDAQIndustrials300 employeesFounded 1991
Verdict: Favorable Risk/Reward — Asymmetric dislocation with hard tangible-book floor

HDSN is trading near tangible book (~$6/sh) after a 40% drawdown from 52W high $10.52, while the AIM Act HFC phase-down provides a structural tailwind to reclaimed refrigerant demand. Q1'26 margin compression (GM 20% vs 31% prior year) is largely a transient ERP-transition + mild-weather event, not a permanent impairment. Zero debt, $19M cash and $130M refrigerant inventory that appreciates as HFC availability contracts create a hard downside floor; aggressive 10% owner (Hartree Partners) accumulation at $5.68–5.97 anchors the setup. Base FV $8.90 (+41%) with meaningful upside optionality if HFC pricing normalizes.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-07-09
79
Hudson Technologies Inc. (HDSN)
Refrigerant reclamation & sales · NASDAQ · Pearl River, NY
"Unlevered balance sheet + regulatory tailwind + insider buying = asymmetric setup at tangible book"
Zero net debt AIM Act tailwind Insider buying $4M+ YTD Margin compression Q1'26 DLA contract expiry Nov'26
Fin. strength
16
/20 pts
EBITDA/FCF
7
/15 pts
Debt/leverage
15
/15 pts
Stage/business
12
/15 pts
Catalysts
8
/10 pts
Reg. risk
7
/8 pts
Risk/reward
6
/7 pts
Management
4
/5 pts
Sector/macro
3
/3 pts
Compliance
1
/2 pts
💡 Fair Value Estimate — EV/EBITDA on FY2027E (normalization year)
Fair value base case
USD 8.90
Range: USD 7.00-USD 12.0
Reference price: USD 6.44 (09/07/2026)
Base upside/downside: +41%

Primary EV/EBITDA on FY2027E as normalization year (post-ERP, post-mild-weather). Implied multiple 8.3x, within +/-3% of nominal 8.5x. Cross-check with tangible book value = $4.14/sh (bear floor); asset-based check confirms hard downside anchor near current price. Scenario weights skewed toward base/bull (80% cumulative) reflecting: (1) unlevered balance sheet removes existential risk, (2) HFC phase-down is a hard-scheduled regulatory tailwind, (3) 10% owner accumulating aggressively at $5.68–5.97. Sensitivity: ±1x multiple = ±$1/sh (11%). ⚠️ Not investment advice.

ComponentAssumptionUSD/share
Core EBITDA value FY27E$42M EBITDA × 8.5x EV/EBITDA (peer median) = $357M EV / 42.05M shares+8.49
Net cash floor($25M FY27E cash − $0M debt) / 42.05M shares+0.59
Inventory appreciation option30% prob × $30M inventory markup from HFC price recovery / 42.05M+0.21
DLA contract renewal risk−25% prob × $15M revenue at risk × 4x multiple / 42.05M−0.36
Discount to present (10% × 1yr)FY27 → FY26 present value at 10% cost of equity−0.03
FV base caseSum: 8.49 + 0.59 + 0.21 − 0.36 − 0.03≈ $8.90
Bull
$13–15
Probability: 30%
AIM Act 2026 step-down triggers HFC price spike +30%; inventory revalues; margin returns to 25%+ GM; DLA renewed with better terms. FY27 EBITDA $55M+ at 10x = $13–15/sh.
Base
$8–10
Probability: 50%
ERP transition completes H2'26; margins recover to 22–25% GM; revenue $260–280M; DLA renewed at similar terms. FY27 EBITDA $40–45M at 8.5x = $8–10/sh.
Bear
$4.50–5.50
Probability: 20%
Extended margin compression through 2026; mild weather 2 years in a row; DLA lost to competitor; refrigerant pricing stays depressed. FY27 EBITDA $25M at 6x + net cash = $4.50–5.50/sh, but tangible book ~$4.15 caps deeper downside.
Methodology: Primary EV/EBITDA on FY2027E as normalization year (post-ERP, post-mild-weather). Implied multiple 8.3x, within +/-3% of nominal 8.5x. Cross-check with tangible book value = $4.14/sh (bear floor); asset-based check confirms hard downside anchor near current price. Scenario weights skewed toward base/bull (80% cumulative) reflecting: (1) unlevered balance sheet removes existential risk, (2) HFC phase-down is a hard-scheduled regulatory tailwind, (3) 10% owner accumulating aggressively at $5.68–5.97. Sensitivity: ±1x multiple = ±$1/sh (11%). ⚠️ Not investment advice. Not investment advice.
⚠️ Methodology note: HDSN market cap ~$266M sits just below the $300M small-cap threshold but is treated here as small-cap edge case given the compelling asymmetry setup. FV built forward on FY2027E EBITDA (normalization year) discounted back, primary method EV/EBITDA cross-checked against tangible book floor.
📊 Capital Structure · Short Interest · Buyback & Dilution
🟢 Short Interest
3.0%
~1.25M shares short of ~42.05M outstanding. Days to cover ~2.1. Interpretation: LOW — no squeeze setup, but also no meaningful downside pressure from shorts.
🟢 Share dilution (1Y)
−1.0%
From ~42.5M to ~42.05M shares. Cause: modest buyback program active; Q1'26 repurchased 416,480 shares for $2.5M. Slight reduction, not dilution.
🟢 Buyback
$2.5M
$2.5M repurchased Q1'26 at avg ~$6.00. Board-authorized $10M program still active. Priority: opportunistic at book value.
Short Interest — context
HDSN — 3.0%
3.0%

Insider transactions: Hartree Partners LP (10% owner) accumulated aggressively June 30–July 2, 2026, buying 764,202 shares at $5.68–5.97 (~$4.4M total) and now holds 4.97M shares. Board members and executives also open-market buying. 10 insider buys vs. 2 insider sells in trailing 12 months. Strong positive signal — insider conviction at current price levels supports the tangible-book floor thesis.

$Financial analysis — FY2026E
Revenue FY2026E
~$260M
+8% YoY vs FY25 ~$240M
Adj. EBITDA FY2026E
~$28M
Compressed 10.8% margin; H2 recovery expected
Net cash
$19M
Zero debt · $40M revolver available
Inventory
$130.7M
Refrigerant stockpile — hard asset with pricing optionality
ItemFY2022FY2023FY2024FY2025Guidance FY2026
Revenue ($M)325.2289.0232~240~260
Gross margin %40%35%28%31%~24%
Adj. EBITDA ($M)1087832~30~28
Net income ($M)755512~10~12
Cash ($M)39727885~25
Total debt ($M)00000
Note: Cash decline FY25→FY26E reflects USA Refrigerants acquisition ($20M) + inventory build ahead of AIM Act step-down. FY24–FY25 figures are estimates from 9M reported data.
Quarterly dynamics — last 5 quarters
MetricQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Revenue ($M)55.367.174.043.660.2
Gross margin %29%31%34%26%20%
Adj. EBITDA ($M)6.810.513.2−0.52.5
End-of-period cash ($M)7582848519
Financial position and sustainability
Gross margin FY26E target
24% / 35%
Cash coverage vs FY OpEx
$19M / ~$55M
Inventory turnover
~1.5x
Insider ownership
~30% (incl. Hartree)
account_tree

Business model — Refrigerant reclamation + industrial gas sales

Dominant US refrigerant reclamation platform + AIM Act tailwind
Hudson operates as the largest US player in refrigerant reclamation, buying used HFC/HCFC refrigerants from HVAC contractors, purifying them at 8 facilities (expanded via 2024 USA Refrigerants + 2025 Refrigerants Inc. acquisitions), and reselling reclaimed product. The AIM Act mandates a 40% step-down in virgin HFC production allowances by 2028 and 85% by 2036, creating structurally rising demand for reclaimed refrigerant. Hudson also has a $50M+ recurring DLA contract for federal HVAC services and a July 2026 licensing agreement with Solstice (Honeywell) for HFO reclamation — securing next-generation refrigerant chemistry supply chain.

Refrigerant Product Sales ~$200-220M FY26E (80% rev) 🟢 core cash cow Virgin + reclaimed HFC/HCFC/HFO sales to HVAC contractors, wholesalers, OEMs. GM 20–30% depending on pricing cycle. AIM Act phase-down = pricing tailwind long-term. RefrigerantSide® Services ~$30-40M FY26E (13% rev) 🟡 stable On-site chiller decontamination, energy audits, leak detection. Higher-margin recurring service revenue (~35–40% GM). Cross-sell driver for product side. Government / DLA Contract ~$10-15M FY26E (5% rev) 🟡 renewal risk Prime contract with US Defense Logistics Agency for federal HVAC gases. Extended to Nov 29, 2026 (+ 2×3mo options to May 27). Renewal is a Q4'26 binary event.

gavel

Legal, regulatory and risk analysis

HFC price volatility
High
Refrigerant prices dropped sharply in Q4'25 - Q1'26 due to inventory oversupply and mild winter. Q1'26 GM compressed to 20% vs 31% prior year. Recovery hinges on 2026 cooling season demand + AIM Act enforcement.
DLA contract renewal
Moderate
Prime DLA contract expires Nov 29, 2026 with 2×3-month options. Currently a bridge modification. Non-renewal would cost ~$10-15M revenue, but 10-year prior relationship favors continuity.
ERP transition execution
Moderate
Q1'26 operating cash flow was −$12.8M partly due to ERP system transition disrupting order-to-cash. Expected to normalize by H2'26. Short-term working capital drag but not structural.
Micro-cap liquidity
Moderate
Market cap $266M sits below institutional cutoff. Average daily volume ~500K shares. Position building/exit requires patience. Amplifies price volatility during earnings.
AIM Act regulatory tailwind
Positive
EPA HFC phase-down schedule locked in: 40% baseline reduction 2024→2028, 70% by 2029, 85% by 2036. Reclamation is legally mandated pathway to meet demand. HDSN has largest US reclamation footprint.
Unlevered balance sheet
Positive
Zero total debt, $19M cash, $40M revolver capacity. No refinancing risk, no covenant risk. Can survive multi-year margin trough without dilution. Tangible book floor at ~$4.14/sh.
10% owner accumulation
Positive
Hartree Partners LP acquired 764K+ shares June 30–July 2, 2026 at $5.68–5.97 (~$4.4M). Now holds 4.97M shares total. Physical commodity trading firm with deep refrigerant market knowledge — informed buyer.
Class action / SEC
Low
No active class action lawsuits identified. No pending SEC investigations. No shelf registration filings recent 12 months. Clean governance record.
article

SWOT analysis

Strengths
  • +Zero debt, $19M cash, $40M revolver — hard downside floor
  • +Largest US refrigerant reclamation network (8 facilities post USA/RI acquisitions)
  • +AIM Act HFC phase-down = structural multi-year tailwind
  • +$130M refrigerant inventory that appreciates with HFC scarcity
  • +HFO licensing deal with Solstice (Honeywell) secures next-gen chemistry
Weaknesses
  • Q1'26 gross margin compressed to 20% (vs 31% prior year)
  • Q1'26 operating cash flow −$12.8M — working capital drag
  • Seasonality: 60% of revenue in Q2-Q3 cooling season
  • One reportable segment — limited diversification
  • Micro-cap liquidity ($266M mkt cap, ~500K daily volume)
Opportunities
  • 2028 HFC step-down (40% baseline reduction) — pricing lift
  • HFO reclamation via Solstice license = new revenue stream
  • Consolidation of fragmented reclamation industry (M&A)
  • Carbon credit trading monetization from reclaimed CO2-equivalent
  • EU F-gas regulation similar to AIM Act — international expansion
Threats
  • !DLA contract non-renewal at Nov 2026 = $10-15M revenue loss
  • !Substitution by natural refrigerants (CO2, ammonia) long-term
  • !EPA rule changes / political shifts weakening AIM Act enforcement
  • !Mild weather two winters in a row = extended demand slump
  • !Chemours/Arkema virgin HFC dumping to defend market share
article

Summary by assessment area

🟢 Financial Risk — LOW
  • Zero debt, net cash $19M, $40M revolver undrawn
  • Tangible book ~$4.14/sh vs price $6.33 — hard floor
  • Buyback active, $2.5M repurchased Q1'26
🟡 Operational Risk — MODERATE
  • Q1'26 GM compression + OCF negative (ERP transition)
  • DLA contract renewal binary event Nov 2026
  • HFC pricing cycle uncertainty near-term
🟢 Structural / R/R — FAVORABLE
  • AIM Act tailwind = multi-year pricing lift
  • Insider buying $4M+ YTD at $5.68-5.97 (10% owner)
  • Asymmetry: +41% base upside vs −13% to tangible book
Sources & Disclaimer

Sources: SEC EDGAR (HDSN 10-K FY2024, 10-Q March 31, 2026), Company press releases (hudsontech.com), Yahoo Finance, StockAnalysis, Fintel, MarketBeat, Simply Wall St, Benzinga analyst ratings, StockTitan Form 4 filings (Hartree Partners), Kavout, StockStory Q1 2026 deep dive. Market data — last verified close 2026-07-08: HDSN ~$6.33, market cap ~$266M, 52W range $4.64–$10.52, ~42.05M shares outstanding, short interest ~3.0%, days to cover ~2.1. ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.